EUVIMEDEUVIMED entdecken
Open Access

A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer

Ruoxue Cai, Shuyi Hu, Feiyang Li, Huanhuan Sha, Guoren Zhou, Ying Fang

Oncology Research · 2026

DOI: 10.32604/or.2025.070893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Ruoxue Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Geriatric Hospital of Nanjing Medical University, Jiangsu Province Official Hospital, The Affiliated Cancer Hospital of Nanji…. Hauptthemen laut MEDLINE: Lung Neoplasms, Chemoradiotherapy, Immune Checkpoint Inhibitors, Small Cell Lung Carcinoma. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsChemoradiotherapyImmune Checkpoint InhibitorsSmall Cell Lung CarcinomaHumansFemaleRetrospective StudiesNeoplasm StagingMaleAgedPrognosisMiddle AgedTreatment OutcomeAdultDiabetes Mellitus, Type 2Immunotherapy

Stichwörter der Autor:innen

Limited-stage small cell lung cancerTNM stagechemoradiotherapyimmunotherapytype 2 diabetes

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, Geriatric Hospital of Nanjing Medical University, Jiangsu Province Official Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, China.
  • Department of Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.

Zitieren

APA

Cai, R., Hu, S., Li, F., Sha, H., Zhou, G., & Fang, Y. (2026). A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer. Oncology Research. https://doi.org/10.32604/or.2025.070893

Vancouver

Cai R, Hu S, Li F, Sha H, Zhou G, Fang Y. A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer. Oncology Research. 2026. doi:10.32604/or.2025.070893

BibTeX
@article{Cai2026,
  author = {Cai, Ruoxue and Hu, Shuyi and Li, Feiyang and Sha, Huanhuan and Zhou, Guoren and Fang, Ying},
  title = {A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.070893}
}
Kostenlos starten →